HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

Dutch Firms Not Updating Product Info Fast Enough Following Safety Alerts

OTC marketing authorization holders in the Netherlands must respond more quickly to safety alerts issued at EU level which require product information updates, says regulator MEB.
Netherlands Drug Review

Health And Wellness Products Trademark Review 15 October, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.


OTC Drugs Dietary Supplements

OTC Zantac Recall: Sanofi Heeds To Potential Ranitidine Contaminant

Firm opts for recall "as a precautionary measure due to inconsistencies in preliminary test results of the active ingredient used in the US and Canadian products." Other firms marketing ranitidine in US have started recalls due to concerns about NDMA since potential problem became known in September.

OTC Drugs Recalls

FDA Warning Letter To SkinPrint Cites GMP Violations, Unapproved New Acne Drug

The Skin Atelier, Inc., dba Skinprint, appears to have discontinued sales of OTC drug products on its website, along with Spot-On With 5% Micro-Benz Benzoyl Peroxide Spot Treatment, an unapproved new drug product that the FDA cited in a 1 October warning letter amid a host of GMP violations.

FDA Enforcement

Boiron Warned Over Use Of Social Media Influencer In French Ad

Using a social media influencer to promote its pro-homeopathy campaign in France without clearly indicating the post was a paid ad has landed Boiron in hot water with local regulators. 
Ad Complaints France

Self-Care Devices May See Extension After EU Commission Admits MDR ‘Inconsistencies’

Self-care medical devices may be included in the four-year “grace period” following implementation of the new EU Medical Devices Regulation as part of an incoming corrigendum to the law, a spokesperson for the European Commission suggested at a recent AESGP meeting.

Health OTC Drugs
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

Takeda Offloads Emerging Market OTCs to Acino

Takeda is shedding some unwanted OTC assets in a number of emerging markets as part of its efforts to pay down debt and focus its portfolio following its acquisition of Shire. 
Deals Emerging Markets

GSK Takes Back Control of Korean OTCs To Combine With Pfizer Megabrands

GSK is set to regain the rights to a portfolio of OTC brands in South Korea which it will combine with Pfizer megabrands such as Advil and Centrum to create a sizable consumer health footprint in the country.
South Korea Health

Perrigo Prioritizes Innovating First After Following OTC Brands To Market

Perrigo’s "national brand better" approach includes adding "better" value to generic equivalents that branded aren't offering, says President and CEO Murray Kessler. Prevacid 24 HR acquisition puts Perrigo at top of 15-mg lansoprazole PPI brand sales as well as in the generics market.

OTC Drugs Commercial
See All

Latest From Business Strategies & Health

Health And Wellness Products Trademark Review 15 October, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.


OTC Drugs Dietary Supplements

OTC Zantac Recall: Sanofi Heeds To Potential Ranitidine Contaminant

Firm opts for recall "as a precautionary measure due to inconsistencies in preliminary test results of the active ingredient used in the US and Canadian products." Other firms marketing ranitidine in US have started recalls due to concerns about NDMA since potential problem became known in September.

OTC Drugs Recalls

ZitSticka Investor BFG Touts Startup’s Grownup Following, ‘And They Have Done It With One Product’

Australia-born ZitSticka, marketer of the Killa patch with microdart technology to address “early-stage” zits, will use $5m in Series A financing to support upcoming product launch activity, it says.
Business Strategies Financing
See All

Latest From Sales & Earnings & Health

Tylenol Relieves Pain For J&J Consumer As Baby Care Relaunch Loses Steam

Tylenol brand boosts J&J US OTC sales 8.4% to $477m, helping balance a 24.1% decline in baby care sales due to restocking reformulated Johnson’s Baby line in 2018, mostly in the US. Firm reports consumer health sales in the US were up 1.7% to $1.39bn.
OTC Drugs Sales & Earnings

Colgate Changes Innovation Strategy To Tap Cultural Trends, Cut Development Time

Colgate changing to be more “agile” and predictive of local trends while also cutting product development time significantly, says CEO Noel Wallace. Approach has worked well in natural toothpaste business, where firm is gaining market share with toothpastes appealing to local preferences.

OTC Drugs Commercial

Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits

Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.
Business Strategies Sales & Earnings
See All

Latest From Legal Issues & Health

J&J Starts First Baby Powder Recall Linked To Asbestos Finding

Recall announcement doesn't mention litigation J&JU faces in multiple states alleging use of Johnson's Baby Powder causes cancer due from talc in formulation. But firm's sensitivity to consumer complaints or adverse event reports linked to brand is clear with talc-related litigation as backdrop.

OTC Drugs Cosmetic Ingredients

Tylenol Relieves Pain For J&J Consumer As Baby Care Relaunch Loses Steam

Tylenol brand boosts J&J US OTC sales 8.4% to $477m, helping balance a 24.1% decline in baby care sales due to restocking reformulated Johnson’s Baby line in 2018, mostly in the US. Firm reports consumer health sales in the US were up 1.7% to $1.39bn.
OTC Drugs Sales & Earnings

Innovating Outside OTC Monograph Lines: Trending Acne Patches, Hand And Foot Antiperspirants

Industry and the FDA agree that the OTC drug monograph system is direly in need of reform, but innovating with noncompliant dosage forms and indications, without approved new drug applications, is a risk companies need to weigh seriously, says Arnall Golden Gregory partner Alan Minsk. The FDA offers perspective on its OTC monographs for acne and antiperspirant products.

United States Regulation
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

Health And Wellness Products Trademark Review 15 October, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.


OTC Drugs Dietary Supplements

Health And Wellness Launches: Vicks Children's, GNC4U, Stance Pre-workout, Lumiday For Women, More

Stance launches Merk pre-workout supplement; Brio offers hemp oils with assurance; vegan omegas from Emerald Health; Anlit has long-life probiotic bites; Nutrawise launches liquid collagen; Natural Recovery Greens powdered CBD drinks; aloe vera immunity drink from LR; Vicks rolls out three-product lineup for children free of artificial dyes and flavors; GNC launches customized subscription vitamin program; and Lumiday supplements by women for women.

Dietary Supplements OTC Drugs

Health And Wellness Products Trademark Review 1 October, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks OTC Drugs
See All

Latest From Ad Campaigns & Health

GSK ‘Goes Hard’ In The UK With $5m Beechams Campaign

GSK hopes new $5m brand revitalization campaign will put its flagship Beechams cold and flu brand at the front of UK consumers' minds this winter.
Health OTC Drugs

Boiron Warned Over Use Of Social Media Influencer In French Ad

Using a social media influencer to promote its pro-homeopathy campaign in France without clearly indicating the post was a paid ad has landed Boiron in hot water with local regulators. 
Ad Complaints France

Bayer's Aleve 'Proven Better' Than Tylenol Claims Fail In J&J Challenge At NAD

Bayer appeals to National Advertising Review Board over NAD’s finding the firm didn't support claims its Aleve OTC provides superior pain-relief to J&J’s Tylenol. It says NAD misunderstands scientific data and it will argue pain studies it submitted were methodologically sound and pain-relief statements were not overly broad.
OTC Drugs Ad Complaints
See All

Latest From Ad Complaints & Health

Boiron Warned Over Use Of Social Media Influencer In French Ad

Using a social media influencer to promote its pro-homeopathy campaign in France without clearly indicating the post was a paid ad has landed Boiron in hot water with local regulators. 
Ad Complaints France

Bayer's Aleve 'Proven Better' Than Tylenol Claims Fail In J&J Challenge At NAD

Bayer appeals to National Advertising Review Board over NAD’s finding the firm didn't support claims its Aleve OTC provides superior pain-relief to J&J’s Tylenol. It says NAD misunderstands scientific data and it will argue pain studies it submitted were methodologically sound and pain-relief statements were not overly broad.
OTC Drugs Ad Complaints

L’Oreal UK Airs '5-Star' Kids Sunscreen Ads With '3-Star' Products On Shelves

ASA says TV and radio ads for Ambre Solair Kids Sensitive Advanced sunscreens aired by Loreal Ltd. business implied that all of the brand's products on shelves met a 5-star rating system administered by Boots drug store chain and widely used in UK.

OTC Drugs Ad Complaints
See All
UsernamePublicRestriction

Register

Advertisement